U.S. Infrastructure Stock News

Chefs' Warehouse stock moves invite a closer look Chefs' Warehouse (CHEF) stock has shown mixed short term performance, with a gain over the past month but a decline over the past week. That pattern is prompting closer attention from investors. See our latest analysis for Chefs' Warehouse. Recent moves fit into a stronger run for Chefs' Warehouse, with a 30 day share price return of 14.42% feeding into a 74.52% year to date share price return and a 3 year total shareholder return above 200%...

Waste Management (WM) is back in focus as fresh valuation work highlights a split picture. Discounted cash flow estimates sit near the current share price, while P/E based comparisons point to a richer market multiple. See our latest analysis for Waste Management. At a share price of US$224.92, Waste Management has seen its 30 day share price return decline 3.54%, while the 3 year total shareholder return of 49.73% and 5 year total shareholder return of 58.34% point to a stronger longer term...

In late July 2026, Alnylam Pharmaceuticals cut its full-year TTR product sales guidance after reassessing growth expectations for the ATTR-CM market, prompting a law firm to continue investigating potential federal securities law violations related to the company’s disclosures. This combination of lowered product expectations and legal scrutiny may influence how investors view the resilience and risks of Alnylam’s RNAi-focused business model. We’ll now examine how the reduced TTR sales...

In recent days, Johnson & Johnson reported past quarterly operational sales growth led by its Innovative Medicine and MedTech businesses and raised its full-year outlook while securing U.S. 510(k) and FDA clearances for the MONARCH QUEST 3 AI-enabled bronchoscopy software update. Taken together, stronger operating performance and regulatory progress in robotic lung procedures underscore how Johnson & Johnson is leaning on innovation across medicines and devices to reinforce its diversified...

When 30-year U.S. Treasury yields touch 5.3%, the math behind every long-term investment gets rewired, and that can quietly reshuffle where risk and reward sit in your portfolio. Higher long-term rates can pressure some stocks while opening fresh angles for others that lean on investment income. This article explains how that backdrop relates to life insurers and annuity providers and highlights 3 stocks directly exposed to this rate story. The three stocks covered next are a sample from a...

Marvell Technology (NasdaqGS:MRVL) has granted Google a warrant to purchase a significant equity stake tied to an expanded AI chip collaboration. The warrant is described as a multibillion dollar opportunity and depends on Google's cumulative purchases of Marvell's custom AI chips. The deal brings Marvell directly into Google's custom semiconductor plans for advanced AI workloads and positions Marvell as a key supplier for hyperscale AI infrastructure. Consider broadening your research to...

Global trade rules are being rewritten in real time, with new tariffs, AI powered border checks and shifting energy alliances reshaping where goods are made. That disruption creates risk for companies tied to complex Asia centric supply chains, and potential openings for those investing in North American capacity. This article explores three stocks exposed to these policy shifts and examines how their onshoring efforts might respond to the latest U.S. trade moves. The stocks in the article...

Gilead Sciences stock has delivered very strong long term returns over the past five years, yet current valuation checks and market multiples still point to the shares screening as undervalued. With recent news flow focused on its HIV and oncology franchises and on legal protection of its U.S. drug pricing, investors are weighing how much of this is already reflected in the price. Gilead Sciences has returned 148.1% over the past five years, which puts recent valuation questions in the...

ZIM Integrated Shipping Services recently reported its second-quarter 2026 results, with net income rising to about US$63.5 million–US$64 million and earnings per share of US$0.53–US$0.64, while revenue grew 9% year-on-year to US$1.78 billion. The company’s outperformance versus earlier consensus expectations, alongside reaffirmed full-year guidance and commentary on a potentially stronger second half and future dividends, highlights how pricing power on Transpacific routes and a modernizing...

Navios Maritime Partners (NMM) drew fresh attention on August 20, 2026 after reporting Q2 results alongside a larger share buyback plan. The combination of earnings data and capital return decisions gives investors new information to assess. See our latest analysis for Navios Maritime Partners. The strong Q2 figures and expanded buyback have come alongside firm momentum in Navios Maritime Partners’ stock, with a 30 day share price return of 15.3% and a 1 year total shareholder return of...

Keurig Dr Pepper (KDP) is drawing fresh attention after rolling out a lime led reformulation across its 7UP range and unveiling a limited time Dr Pepper Shake collaboration with Portillo’s, shortly after releasing mixed quarterly earnings. See our latest analysis for Keurig Dr Pepper. For investors, the recent 7UP refresh and Dr Pepper Shake launch come after a mixed earnings release and a period where Keurig Dr Pepper’s share price has shown improving short term momentum, with a 90 day share...

Teladoc Health (TDOC) investors are watching a boardroom change after director David B. Snow Jr. announced plans to retire from the board on September 30, 2026, citing personal reasons without any disagreement. See our latest analysis for Teladoc Health. Against this boardroom update, Teladoc Health’s 1 day share price return of 2.94% sits in contrast to a 30 day share price return that declined 30.98%, while the 5 year total shareholder return is down 95.40%, signaling pressure on long term...

Sana Biotechnology, Inc. reported second-quarter 2026 results showing net loss of US$63.64 million and basic loss per share of US$0.22, both lower than a year earlier, and a six-month net loss of US$110.85 million with loss per share of US$0.39. The continued reduction in net loss and loss per share over both the quarter and half-year suggests tightening cost controls and improving financial efficiency. We’ll now examine how Sana Biotechnology’s narrower net loss and reduced loss per share...

After a strong three year run that has seen PNC Financial Services Group deliver a 130.6% total return, the valuation picture is more nuanced, with the Excess Returns intrinsic value estimate pointing to meaningful upside while the market multiples suggest the stock is closer to fairly priced. Over the past three years, PNC Financial Services Group has returned 130.6%, which puts more weight on whether the current price still leaves a margin of safety. Future valuation can be influenced by...

Fluor Corporation recently reported its second-quarter 2026 results, showing sales of US$4,329 million versus US$3,978 million a year earlier, but net income dropped to US$114 million from a very large US$2,460 million, alongside a continued share repurchase program. Over the first half of 2026, Fluor generated relatively flat sales of US$7,991 million while net income fell sharply, even as it retired 6,135,847 shares for US$299.06 million, bringing total buybacks since 2011 to 73,310,278...

Earlier in August 2026, Bloom Energy introduced Power Connect, a factory-integrated deployment system that moves key electrical work offsite and aims to cut onsite power installation time by over 40% for customers such as AI data centers and microgrids. This shift toward pre-wired, pre-tested U.S.-assembled systems not only simplifies complex projects but also reinforces Bloom’s positioning as an enabler of faster, more predictable power delivery for digital infrastructure. We’ll now examine...

In August 2026, Hormel Foods Corporation introduced a co-branded HORMEL® Chili & OMAHA STEAKS® 100% Natural Beef Chili with Beans nationwide and rolled out a PLANTERS fall 2026 collection featuring limited-time seasonal nut flavors and an expanded Special Reserve line across major retailers. By pairing a premium Omaha Steaks collaboration with seasonal PLANTERS innovations, Hormel is leaning into higher-quality, occasion-based eating experiences that can deepen brand relevance across both...

Deere (DE) just reported third quarter and nine month results to 2 August 2026, giving investors fresh detail on how its agriculture and construction equipment business is tracking this year. See our latest analysis for Deere. At a share price of US$580.63, Deere has given investors a 24.39% year to date share price return and a 19.32% total shareholder return over the past year. However, the 7 day share price return declined 6.32% after the earnings release, hinting that recent momentum is...

Veeco Instruments Inc. recently filed a US$175.56 million shelf registration to offer 3,500,000 shares of common stock in an ESOP-related transaction and has already presented at the now-concluded 7th Annual Needham Virtual Semiconductor & SemiCap 1×1 Conference held on August 19, 2026. The shelf registration highlights Veeco’s potential to raise capital while expanding employee ownership, a move that can affect both dilution expectations and perceptions of long-term workforce...

Circle Internet Group stock has rebounded over the past month, yet after a year in which the share price fell 43% and the broader valuation checks lean expensive, investors are still weighing how much downside risk is already in the price. The share price decline of 43% over the past year puts the recent gains into context and raises the question of whether this is a reset or a value trap. Circle Internet Group's role in Europe’s MiCA regime and new initiatives such as cirBTC can support...

Improved earnings and return to net income in focus Medical Properties Trust (MPT) recently reported second quarter and first half 2026 results that showed a shift from a large net loss a year earlier to net income year to date, drawing fresh attention to the stock. See our latest analysis for Medical Properties Trust. The latest earnings swing has arrived alongside mixed share price moves for Medical Properties Trust, with the stock up 3.48% on a 1-day share price return and 2.72% over 7...

Howard Hughes Holdings stock has fallen about 21.3% over the past five years, yet the current valuation work suggests the market may be pricing it too cautiously. Both the Discounted Cash Flow (DCF) intrinsic value estimate and the earnings based multiples point to the shares trading at a discount to what the underlying cash flows may justify. Over five years the share price decline of roughly 21.3% means long term holders have experienced a material capital loss. Future cash flow from...

Altria Group has almost doubled investors' money over the past five years, yet the current checks on the stock point to a valuation that looks cheaper on earnings multiples than a simple headline return might suggest. Over the last 5 years, Altria Group has delivered a total return of 99.7%, which is a meaningful gain for a mature tobacco stock and sets the context for judging whether the current price still offers value. For a business like Altria Group, steady cash generation and the...

McKesson stock has delivered a very strong 5 year return, yet the current share price of US$853.71 still screens as undervalued on both an intrinsic value estimate using a Discounted Cash Flow (DCF) model and on market multiples. McKesson has returned about 3.4x over the past 5 years, which puts long term holders in a very strong position and raises the question of how much upside could reasonably be left. Expectations for continued cash flow generation can support the current valuation,...